Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01765933 · ClinicalTrials.gov registry record · NA
Pharmacokinetic Effects of Oral DMAA
A NA study, sponsored by University of Memphis.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT01765933 is a NA study that has completed, run by University of Memphis. The registered enrollment target is 8 participants.
The verdict
NCT01765933, a NA study, has completed, sponsored by University of Memphis.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
1,3-dimethylamylamine (DMAA) has become increasingly popular as a component of dietary supplements. It is also used within "party pills," often in conjunction with alcohol and other drugs, and has been associated with untoward effects when abused at high dosages. To our knowledge, no studies have been conducted to determine the combined pharmacokinetic profile and physiologic responses of DMAA. To conclude on the safety profile of DMAA based solely on case reports would be problematic, in particular when accepting testimony from patients in uncontrolled environment, potentially under the influence of alcohol and other drugs. This is especially true in light of the fact that no prospective studies have shown these effects. Hence, the intent of the present study was to determine the pharmacokinetic profile of a single 25mg oral dosage of DMAA alone through 24 hours post-ingestion. This represents a typical dosage within one serving of many popular dietary supplements containing DMAA.
Interventions
- DIETARY_SUPPLEMENT DMAA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2012-04 |
| Est. Completion | 2012-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01765933
The ClinicalTrials.gov registry entry for NCT01765933 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Memphis, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DMAA is the first listed.
NCT01765933 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01765933 about?
NCT01765933 is a clinical study titled "Pharmacokinetic Effects of Oral DMAA". 1,3-dimethylamylamine (DMAA) has become increasingly popular as a component of dietary supplements. It is also used within "party pills," often in conjunction with alcohol and other drugs, and has been associated with untoward effects when abused at high dosages. To our knowledge, no studies have be...
What is the current status of trial NCT01765933?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2012-04. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01765933?
The interventions under investigation include: DMAA (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01765933?
This trial is sponsored by University of Memphis, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.